KCNQ1 Gene Long QT syndrome type 1 Genetic Test
At DNA Labs UAE, we offer the KCNQ1 Gene Long QT syndrome type 1 Genetic Test to diagnose and manage Long QT syndrome type 1 (LQT1), a genetic disorder that affects the heart’s electrical system.
Test Components
- Price: 4400.0 AED
Sample Condition
We accept blood samples, extracted DNA samples, or one drop of blood on an FTA Card for this test.
Report Delivery
Test results are typically delivered within 3 to 4 weeks.
Method
We use NGS (Next-Generation Sequencing) technology for this genetic test.
Test Type
This test is classified under Cardiovascular Pneumology Disorders.
Doctor
A cardiologist will oversee the KCNQ1 Gene Long QT syndrome type 1 Genetic Test.
Test Department
This test is conducted by our Genetics department.
Pre Test Information
Prior to the test, we recommend a genetic counseling session to gather the clinical history of the patient and to draw a pedigree chart of family members affected by KCNQ1 Gene Long QT syndrome type 1.
Test Details
The KCNQ1 gene is associated with Long QT syndrome type 1 (LQT1), a genetic disorder that causes abnormalities in the heart’s electrical system. This can result in prolonged QT intervals on an electrocardiogram (ECG), leading to potentially life-threatening arrhythmias.
Our NGS genetic testing technique allows for the simultaneous analysis of multiple genes, including the KCNQ1 gene. By analyzing a DNA sample obtained from blood or saliva, we can identify any variations or mutations in the KCNQ1 gene that are known to be associated with LQT1.
If a mutation is found, it can help confirm a diagnosis of LQT1 and guide treatment decisions, such as medication options or the need for implantable cardioverter-defibrillator (ICD) placement.
It is important to note that genetic testing for LQT1 is typically recommended for individuals with a personal or family history of prolonged QT intervals or sudden cardiac death. The test results should be interpreted by a healthcare professional with expertise in genetics and cardiovascular medicine.
Test Name | KCNQ1 Gene Long QT syndrome type 1 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Cardiovascular Pneumology Disorders |
Doctor | Cardiologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for KCNQ1 Gene Long QT syndrome type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with KCNQ1 Gene Long QT syndrome type 1 NGS Genetic DNA Test gene KCNQ1 |
Test Details |
The KCNQ1 gene is associated with Long QT syndrome type 1 (LQT1), which is a genetic disorder that affects the heart’s electrical system. LQT1 is characterized by a prolonged QT interval on an electrocardiogram (ECG), which can lead to abnormal heart rhythms and potentially life-threatening arrhythmias. NGS (Next-Generation Sequencing) is a genetic testing technique that allows for the simultaneous analysis of multiple genes, including the KCNQ1 gene, to identify any variations or mutations that may be present. This type of genetic testing can provide valuable information for diagnosing and managing LQT1. The KCNQ1 gene NGS genetic test involves obtaining a DNA sample, usually through a blood sample or saliva sample, and analyzing it using NGS technology. The test looks for variations or mutations in the KCNQ1 gene that are known to be associated with LQT1. If a mutation is identified, it can help confirm a diagnosis of LQT1 and guide treatment decisions, such as medication options or the need for implantable cardioverter-defibrillator (ICD) placement. It is important to note that genetic testing for LQT1 is typically recommended for individuals who have a personal or family history of prolonged QT intervals or sudden cardiac death. The test results should be interpreted by a healthcare professional with expertise in genetics and cardiovascular medicine. |